Global Peptide Therapeutics Market Professional Survey Report 2017

Publisher Name :
Date: 12-Sep-2017
No. of pages: 107
Inquire Before Buying

This report studies Peptide Therapeutics in Global market, especially in North America, China, Europe, Southeast Asia, Japan and India, with production, revenue, consumption, import and export in these regions, from 2012 to 2016, and forecast to 2022.

This report focuses on top manufacturers in global market, with production, price, revenue and market share for each manufacturer, covering

- Pfizer

- Eli Lilly and Company

- Bachem Holding

- Amgen

- Roche

- GlaxoSmithKline

- Novartis

- Sanofi

- Takeda Pharmaceutical Company

- Teva Pharmaceutical

On the basis of product, this report displays the production, revenue, price, market share and growth rate of each type, primarily split into

- by Phase

- - Liquid Phase

- - Solid Phase

- - Hybrid Phase

- by Type of Molecule

- - Vasopressin

- - Somatostatin

- - Calcitonin

- - Immunopeptide

- - Natriuretic

- - Others

By Application, the market can be split into

- Hospitals Pharmacies

- Retail Pharmacies

- Drug Stores

- E-Commerce

By Regions, this report covers (we can add the regions/countries as you want)

- North America

- China

- Europe

- Southeast Asia

- Japan

- India

If you have any special requirements, please let us know and we will offer you the report as you want.

Global Peptide Therapeutics Market Professional Survey Report 2017

Table of Contents
Global Peptide Therapeutics Market Professional Survey Report 2017
1 Industry Overview of Peptide Therapeutics
1.1 Definition and Specifications of Peptide Therapeutics
1.1.1 Definition of Peptide Therapeutics
1.1.2 Specifications of Peptide Therapeutics
1.2 Classification of Peptide Therapeutics
1.2.1 Liquid Phase
1.2.2 Solid Phase
1.2.3 Hybrid Phase
1.3 Applications of Peptide Therapeutics
1.3.1 Hospitals Pharmacies
1.3.2 Retail Pharmacies
1.3.3 Drug Stores
1.3.4 E-Commerce
1.4 Market Segment by Regions
1.4.1 North America
1.4.2 China
1.4.3 Europe
1.4.4 Southeast Asia
1.4.5 Japan
1.4.6 India
2 Manufacturing Cost Structure Analysis of Peptide Therapeutics
2.1 Raw Material and Suppliers
2.2 Manufacturing Cost Structure Analysis of Peptide Therapeutics
2.3 Manufacturing Process Analysis of Peptide Therapeutics
2.4 Industry Chain Structure of Peptide Therapeutics
3 Technical Data and Manufacturing Plants Analysis of Peptide Therapeutics
3.1 Capacity and Commercial Production Date of Global Peptide Therapeutics Major Manufacturers in 2016
3.2 Manufacturing Plants Distribution of Global Peptide Therapeutics Major Manufacturers in 2016
3.3 R&D Status and Technology Source of Global Peptide Therapeutics Major Manufacturers in 2016
3.4 Raw Materials Sources Analysis of Global Peptide Therapeutics Major Manufacturers in 2016
4 Global Peptide Therapeutics Overall Market Overview
4.1 2012-2017E Overall Market Analysis
4.2 Capacity Analysis
4.2.1 2012-2017E Global Peptide Therapeutics Capacity and Growth Rate Analysis
4.2.2 2016 Peptide Therapeutics Capacity Analysis (Company Segment)
4.3 Sales Analysis
4.3.1 2012-2017E Global Peptide Therapeutics Sales and Growth Rate Analysis
4.3.2 2016 Peptide Therapeutics Sales Analysis (Company Segment)
4.4 Sales Price Analysis
4.4.1 2012-2017E Global Peptide Therapeutics Sales Price
4.4.2 2016 Peptide Therapeutics Sales Price Analysis (Company Segment)
5 Peptide Therapeutics Regional Market Analysis
5.1 North America Peptide Therapeutics Market Analysis
5.1.1 North America Peptide Therapeutics Market Overview
5.1.2 North America 2012-2017E Peptide Therapeutics Local Supply, Import, Export, Local Consumption Analysis
5.1.3 North America 2012-2017E Peptide Therapeutics Sales Price Analysis
5.1.4 North America 2016 Peptide Therapeutics Market Share Analysis
5.2 China Peptide Therapeutics Market Analysis
5.2.1 China Peptide Therapeutics Market Overview
5.2.2 China 2012-2017E Peptide Therapeutics Local Supply, Import, Export, Local Consumption Analysis
5.2.3 China 2012-2017E Peptide Therapeutics Sales Price Analysis
5.2.4 China 2016 Peptide Therapeutics Market Share Analysis
5.3 Europe Peptide Therapeutics Market Analysis
5.3.1 Europe Peptide Therapeutics Market Overview
5.3.2 Europe 2012-2017E Peptide Therapeutics Local Supply, Import, Export, Local Consumption Analysis
5.3.3 Europe 2012-2017E Peptide Therapeutics Sales Price Analysis
5.3.4 Europe 2016 Peptide Therapeutics Market Share Analysis
5.4 Southeast Asia Peptide Therapeutics Market Analysis
5.4.1 Southeast Asia Peptide Therapeutics Market Overview
5.4.2 Southeast Asia 2012-2017E Peptide Therapeutics Local Supply, Import, Export, Local Consumption Analysis
5.4.3 Southeast Asia 2012-2017E Peptide Therapeutics Sales Price Analysis
5.4.4 Southeast Asia 2016 Peptide Therapeutics Market Share Analysis
5.5 Japan Peptide Therapeutics Market Analysis
5.5.1 Japan Peptide Therapeutics Market Overview
5.5.2 Japan 2012-2017E Peptide Therapeutics Local Supply, Import, Export, Local Consumption Analysis
5.5.3 Japan 2012-2017E Peptide Therapeutics Sales Price Analysis
5.5.4 Japan 2016 Peptide Therapeutics Market Share Analysis
5.6 India Peptide Therapeutics Market Analysis
5.6.1 India Peptide Therapeutics Market Overview
5.6.2 India 2012-2017E Peptide Therapeutics Local Supply, Import, Export, Local Consumption Analysis
5.6.3 India 2012-2017E Peptide Therapeutics Sales Price Analysis
5.6.4 India 2016 Peptide Therapeutics Market Share Analysis
6 Global 2012-2017E Peptide Therapeutics Segment Market Analysis (by Type)
6.1 Global 2012-2017E Peptide Therapeutics Sales by Type
6.2 Different Types of Peptide Therapeutics Product Interview Price Analysis
6.3 Different Types of Peptide Therapeutics Product Driving Factors Analysis
6.3.1 by Phase of Peptide Therapeutics Growth Driving Factor Analysis
6.3.2 by Type of Molecule of Peptide Therapeutics Growth Driving Factor Analysis
7 Global 2012-2017E Peptide Therapeutics Segment Market Analysis (by Application)
7.1 Global 2012-2017E Peptide Therapeutics Consumption by Application
7.2 Different Application of Peptide Therapeutics Product Interview Price Analysis
7.3 Different Application of Peptide Therapeutics Product Driving Factors Analysis
7.3.1 Hospitals Pharmacies of Peptide Therapeutics Growth Driving Factor Analysis
7.3.2 Retail Pharmacies of Peptide Therapeutics Growth Driving Factor Analysis
7.3.3 Drug Stores of Peptide Therapeutics Growth Driving Factor Analysis
7.3.4 E-Commerce of Peptide Therapeutics Growth Driving Factor Analysis
8 Major Manufacturers Analysis of Peptide Therapeutics
8.1 Pfizer
8.1.1 Company Profile
8.1.2 Product Picture and Specifications
8.1.2.1 Product A
8.1.2.2 Product B
8.1.3 Pfizer 2016 Peptide Therapeutics Sales, Ex-factory Price, Revenue, Gross Margin Analysis
8.1.4 Pfizer 2016 Peptide Therapeutics Business Region Distribution Analysis
8.2 Eli Lilly and Company
8.2.1 Company Profile
8.2.2 Product Picture and Specifications
8.2.2.1 Product A
8.2.2.2 Product B
8.2.3 Eli Lilly and Company 2016 Peptide Therapeutics Sales, Ex-factory Price, Revenue, Gross Margin Analysis
8.2.4 Eli Lilly and Company 2016 Peptide Therapeutics Business Region Distribution Analysis
8.3 Bachem Holding
8.3.1 Company Profile
8.3.2 Product Picture and Specifications
8.3.2.1 Product A
8.3.2.2 Product B
8.3.3 Bachem Holding 2016 Peptide Therapeutics Sales, Ex-factory Price, Revenue, Gross Margin Analysis
8.3.4 Bachem Holding 2016 Peptide Therapeutics Business Region Distribution Analysis
8.4 Amgen
8.4.1 Company Profile
8.4.2 Product Picture and Specifications
8.4.2.1 Product A
8.4.2.2 Product B
8.4.3 Amgen 2016 Peptide Therapeutics Sales, Ex-factory Price, Revenue, Gross Margin Analysis
8.4.4 Amgen 2016 Peptide Therapeutics Business Region Distribution Analysis
8.5 Roche
8.5.1 Company Profile
8.5.2 Product Picture and Specifications
8.5.2.1 Product A
8.5.2.2 Product B
8.5.3 Roche 2016 Peptide Therapeutics Sales, Ex-factory Price, Revenue, Gross Margin Analysis
8.5.4 Roche 2016 Peptide Therapeutics Business Region Distribution Analysis
8.6 GlaxoSmithKline
8.6.1 Company Profile
8.6.2 Product Picture and Specifications
8.6.2.1 Product A
8.6.2.2 Product B
8.6.3 GlaxoSmithKline 2016 Peptide Therapeutics Sales, Ex-factory Price, Revenue, Gross Margin Analysis
8.6.4 GlaxoSmithKline 2016 Peptide Therapeutics Business Region Distribution Analysis
8.7 Novartis
8.7.1 Company Profile
8.7.2 Product Picture and Specifications
8.7.2.1 Product A
8.7.2.2 Product B
8.7.3 Novartis 2016 Peptide Therapeutics Sales, Ex-factory Price, Revenue, Gross Margin Analysis
8.7.4 Novartis 2016 Peptide Therapeutics Business Region Distribution Analysis
8.8 Sanofi
8.8.1 Company Profile
8.8.2 Product Picture and Specifications
8.8.2.1 Product A
8.8.2.2 Product B
8.8.3 Sanofi 2016 Peptide Therapeutics Sales, Ex-factory Price, Revenue, Gross Margin Analysis
8.8.4 Sanofi 2016 Peptide Therapeutics Business Region Distribution Analysis
8.9 Takeda Pharmaceutical Company
8.9.1 Company Profile
8.9.2 Product Picture and Specifications
8.9.2.1 Product A
8.9.2.2 Product B
8.9.3 Takeda Pharmaceutical Company 2016 Peptide Therapeutics Sales, Ex-factory Price, Revenue, Gross Margin Analysis
8.9.4 Takeda Pharmaceutical Company 2016 Peptide Therapeutics Business Region Distribution Analysis
8.10 Teva Pharmaceutical
8.10.1 Company Profile
8.10.2 Product Picture and Specifications
8.10.2.1 Product A
8.10.2.2 Product B
8.10.3 Teva Pharmaceutical 2016 Peptide Therapeutics Sales, Ex-factory Price, Revenue, Gross Margin Analysis
8.10.4 Teva Pharmaceutical 2016 Peptide Therapeutics Business Region Distribution Analysis
9 Development Trend of Analysis of Peptide Therapeutics Market
9.1 Global Peptide Therapeutics Market Trend Analysis
9.1.1 Global 2017-2022 Peptide Therapeutics Market Size (Volume and Value) Forecast
9.1.2 Global 2017-2022 Peptide Therapeutics Sales Price Forecast
9.2 Peptide Therapeutics Regional Market Trend
9.2.1 North America 2017-2022 Peptide Therapeutics Consumption Forecast
9.2.2 China 2017-2022 Peptide Therapeutics Consumption Forecast
9.2.3 Europe 2017-2022 Peptide Therapeutics Consumption Forecast
9.2.4 Southeast Asia 2017-2022 Peptide Therapeutics Consumption Forecast
9.2.5 Japan 2017-2022 Peptide Therapeutics Consumption Forecast
9.2.6 India 2017-2022 Peptide Therapeutics Consumption Forecast
9.3 Peptide Therapeutics Market Trend (Product Type)
9.4 Peptide Therapeutics Market Trend (Application)
10 Peptide Therapeutics Marketing Type Analysis
10.1 Peptide Therapeutics Regional Marketing Type Analysis
10.2 Peptide Therapeutics International Trade Type Analysis
10.3 Traders or Distributors with Contact Information of Peptide Therapeutics by Region
10.4 Peptide Therapeutics Supply Chain Analysis
11 Consumers Analysis of Peptide Therapeutics
11.1 Consumer 1 Analysis
11.2 Consumer 2 Analysis
11.3 Consumer 3 Analysis
11.4 Consumer 4 Analysis
…
12 Conclusion of the Global Peptide Therapeutics Market Professional Survey Report 2017
Methodology
Analyst Introduction
Data Source
List of Tables and Figures
Figure Picture of Peptide Therapeutics
Table Product Specifications of Peptide Therapeutics
Table Classification of Peptide Therapeutics
Figure Global Production Market Share of Peptide Therapeutics by Type in 2016
Figure Liquid Phase Picture
Table Major Manufacturers of Liquid Phase
Figure Solid Phase Picture
Table Major Manufacturers of Solid Phase
Figure Hybrid Phase Picture
Table Major Manufacturers of Hybrid Phase
Table Applications of Peptide Therapeutics
Figure Global Consumption Volume Market Share of Peptide Therapeutics by Application in 2016
Figure Hospitals Pharmacies Examples
Table Major Consumers in Hospitals Pharmacies
Figure Retail Pharmacies Examples
Table Major Consumers in Retail Pharmacies
Figure Drug Stores Examples
Table Major Consumers in Drug Stores
Figure E-Commerce Examples
Table Major Consumers in E-Commerce
Figure Market Share of Peptide Therapeutics by Regions
Figure North America Peptide Therapeutics Market Size (Million USD) (2012-2022)
Figure China Peptide Therapeutics Market Size (Million USD) (2012-2022)
Figure Europe Peptide Therapeutics Market Size (Million USD) (2012-2022)
Figure Southeast Asia Peptide Therapeutics Market Size (Million USD) (2012-2022)
Figure Japan Peptide Therapeutics Market Size (Million USD) (2012-2022)
Figure India Peptide Therapeutics Market Size (Million USD) (2012-2022)
Table Peptide Therapeutics Raw Material and Suppliers
Table Manufacturing Cost Structure Analysis of Peptide Therapeutics in 2016
Figure Manufacturing Process Analysis of Peptide Therapeutics
Figure Industry Chain Structure of Peptide Therapeutics
Table Capacity and Commercial Production Date of Global Peptide Therapeutics Major Manufacturers in 2016
Table Manufacturing Plants Distribution of Global Peptide Therapeutics Major Manufacturers in 2016
Table R&D Status and Technology Source of Global Peptide Therapeutics Major Manufacturers in 2016
Table Raw Materials Sources Analysis of Global Peptide Therapeutics Major Manufacturers in 2016
Table Global Capacity, Sales , Price, Cost, Sales Revenue (M USD) and Gross Margin of Peptide Therapeutics 2012-2017
Figure Global 2012-2017E Peptide Therapeutics Market Size (Volume) and Growth Rate
Figure Global 2012-2017E Peptide Therapeutics Market Size (Value) and Growth Rate
Table 2012-2017E Global Peptide Therapeutics Capacity and Growth Rate
Table 2016 Global Peptide Therapeutics Capacity (K Units) List (Company Segment)
Table 2012-2017E Global Peptide Therapeutics Sales (K Units) and Growth Rate
Table 2016 Global Peptide Therapeutics Sales (K Units) List (Company Segment)
Table 2012-2017E Global Peptide Therapeutics Sales Price (USD/Unit)
Table 2016 Global Peptide Therapeutics Sales Price (USD/Unit) List (Company Segment)
Figure North America Capacity Overview
Table North America Supply, Import, Export and Consumption (K Units) of Peptide Therapeutics 2012-2017E
Figure North America 2012-2017E Peptide Therapeutics Sales Price (USD/Unit)
Figure North America 2016 Peptide Therapeutics Sales Market Share
Figure China Capacity Overview
Table China Supply, Import, Export and Consumption (K Units) of Peptide Therapeutics 2012-2017E
Figure China 2012-2017E Peptide Therapeutics Sales Price (USD/Unit)
Figure China 2016 Peptide Therapeutics Sales Market Share
Figure Europe Capacity Overview
Table Europe Supply, Import, Export and Consumption (K Units) of Peptide Therapeutics 2012-2017E
Figure Europe 2012-2017E Peptide Therapeutics Sales Price (USD/Unit)
Figure Europe 2016 Peptide Therapeutics Sales Market Share
Figure Southeast Asia Capacity Overview
Table Southeast Asia Supply, Import, Export and Consumption (K Units) of Peptide Therapeutics 2012-2017E
Figure Southeast Asia 2012-2017E Peptide Therapeutics Sales Price (USD/Unit)
Figure Southeast Asia 2016 Peptide Therapeutics Sales Market Share
Figure Japan Capacity Overview
Table Japan Supply, Import, Export and Consumption (K Units) of Peptide Therapeutics 2012-2017E
Figure Japan 2012-2017E Peptide Therapeutics Sales Price (USD/Unit)
Figure Japan 2016 Peptide Therapeutics Sales Market Share
Figure India Capacity Overview
Table India Supply, Import, Export and Consumption (K Units) of Peptide Therapeutics 2012-2017E
Figure India 2012-2017E Peptide Therapeutics Sales Price (USD/Unit)
Figure India 2016 Peptide Therapeutics Sales Market Share
Table Global 2012-2017E Peptide Therapeutics Sales (K Units) by Type
Table Different Types Peptide Therapeutics Product Interview Price
Table Global 2012-2017E Peptide Therapeutics Sales (K Units) by Application
Table Different Application Peptide Therapeutics Product Interview Price
Table Pfizer Information List
Table Product A Overview
Table Product B Overview
Table 2016 Pfizer Peptide Therapeutics Revenue (Million USD), Sales (K Units), Ex-factory Price (USD/Unit)
Figure 2016 Pfizer Peptide Therapeutics Business Region Distribution
Table Eli Lilly and Company Information List
Table Product A Overview
Table Product B Overview
Table 2016 Eli Lilly and Company Peptide Therapeutics Revenue (Million USD), Sales (K Units), Ex-factory Price (USD/Unit)
Figure 2016 Eli Lilly and Company Peptide Therapeutics Business Region Distribution
Table Bachem Holding Information List
Table Product A Overview
Table Product B Overview
Table 2015 Bachem Holding Peptide Therapeutics Revenue (Million USD), Sales (K Units), Ex-factory Price (USD/Unit)
Figure 2016 Bachem Holding Peptide Therapeutics Business Region Distribution
Table Amgen Information List
Table Product A Overview
Table Product B Overview
Table 2016 Amgen Peptide Therapeutics Revenue (Million USD), Sales (K Units), Ex-factory Price (USD/Unit)
Figure 2016 Amgen Peptide Therapeutics Business Region Distribution
Table Roche Information List
Table Product A Overview
Table Product B Overview
Table 2016 Roche Peptide Therapeutics Revenue (Million USD), Sales (K Units), Ex-factory Price (USD/Unit)
Figure 2016 Roche Peptide Therapeutics Business Region Distribution
Table GlaxoSmithKline Information List
Table Product A Overview
Table Product B Overview
Table 2016 GlaxoSmithKline Peptide Therapeutics Revenue (Million USD), Sales (K Units), Ex-factory Price (USD/Unit)
Figure 2016 GlaxoSmithKline Peptide Therapeutics Business Region Distribution
Table Novartis Information List
Table Product A Overview
Table Product B Overview
Table 2016 Novartis Peptide Therapeutics Revenue (Million USD), Sales (K Units), Ex-factory Price (USD/Unit)
Figure 2016 Novartis Peptide Therapeutics Business Region Distribution
Table Sanofi Information List
Table Product A Overview
Table Product B Overview
Table 2016 Sanofi Peptide Therapeutics Revenue (Million USD), Sales (K Units), Ex-factory Price (USD/Unit)
Figure 2016 Sanofi Peptide Therapeutics Business Region Distribution
Table Takeda Pharmaceutical Company Information List
Table Product A Overview
Table Product B Overview
Table 2016 Takeda Pharmaceutical Company Peptide Therapeutics Revenue (Million USD), Sales (K Units), Ex-factory Price (USD/Unit)
Figure 2016 Takeda Pharmaceutical Company Peptide Therapeutics Business Region Distribution
Table Teva Pharmaceutical Information List
Table Product A Overview
Table Product B Overview
Table 2016 Teva Pharmaceutical Peptide Therapeutics Revenue (Million USD), Sales (K Units), Ex-factory Price (USD/Unit)
Figure 2016 Teva Pharmaceutical Peptide Therapeutics Business Region Distribution
Figure Global 2017-2022 Peptide Therapeutics Market Size (K Units) and Growth Rate Forecast
Figure Global 2017-2022 Peptide Therapeutics Market Size (Million USD) and Growth Rate Forecast
Figure Global 2017-2022 Peptide Therapeutics Sales Price (USD/Unit) Forecast
Figure North America 2017-2022 Peptide Therapeutics Consumption Volume (K Units) and Growth Rate Forecast
Figure China 2017-2022 Peptide Therapeutics Consumption Volume (K Units) and Growth Rate Forecast
Figure Europe 2017-2022 Peptide Therapeutics Consumption Volume (K Units) and Growth Rate Forecast
Figure Southeast Asia 2017-2022 Peptide Therapeutics Consumption Volume (K Units) and Growth Rate Forecast
Figure Japan 2017-2022 Peptide Therapeutics Consumption Volume (K Units) and Growth Rate Forecast
Figure India 2017-2022 Peptide Therapeutics Consumption Volume (K Units) and Growth Rate Forecast
Table Global Sales Volume (K Units) of Peptide Therapeutics by Type 2017-2022
Table Global Consumption Volume (K Units) of Peptide Therapeutics by Application 2017-2022
Table Traders or Distributors with Contact Information of Peptide Therapeutics by Region
  • Global Brachytherapy Afterloaders, Brachytherapy Seeds Sales Market Report 2017
    Published: 22-Nov-2017        Price: US 4000 Onwards        Pages: 100
    In this report, the global Brachytherapy Afterloaders, Brachytherapy Seeds market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022. Geographically, this report split global into several key Regions, with sales (K Units), revenue (Million USD), market share and growth rate of Brachytherapy Afterloaders, Brachytherapy Seeds for these regions, from 2012 to 2022 (forecast), covering - ......
  • Hypercholesterolemia - Pipeline Review, H2 2017
    Published: 21-Nov-2017        Price: US 2000 Onwards        Pages: 209
    Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Hypercholesterolemia - Pipeline Review, H2 2017, provides an overview of the Hypercholesterolemia (Metabolic Disorders) pipeline landscape.Hypercholesterolemia arises due to high levels of cholesterol in the blood. These abnormal levels may lead to various diseases especially cardiovascular diseases. Cholesterol deposit in the arteries and may cause the narrowing of blood vessels hence restricting the blood fl......
  • Heterozygous familial hypercholesterolemia (heFH) - Pipeline Review, H2 2017
    Published: 21-Nov-2017        Price: US 2000 Onwards        Pages: 40
    Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Heterozygous familial hypercholesterolemia (heFH) - Pipeline Review, H2 2017, provides an overview of the Heterozygous familial hypercholesterolemia (heFH) (Metabolic Disorders) pipeline landscape.Heterozygous familial hypercholesterolemia (HeFH) is a genetic disorder caused due to a mutation (alteration) of FH from one (affected) parent. Symptoms include xanthesmas, corneal arcus, aortic rupture and periphera......
  • Homozygous Familial Hypercholesterolemia (HoFH) - Pipeline Review, H2 2017
    Published: 21-Nov-2017        Price: US 2000 Onwards        Pages: 83
    Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Homozygous Familial Hypercholesterolemia (HoFH) - Pipeline Review, H2 2017, provides an overview of the Homozygous Familial Hypercholesterolemia (HoFH) (Metabolic Disorders) pipeline landscape.Homozygous familial hypercholesterolemia is a genetic disorder which is caused due to mutation from both parents. HoFH causes LDL cholesterol level to be very high. Symptoms include xanthelasmas, chest pain and sores on ......
  • Axial Spondyloarthritis - Pipeline Review, H2 2017
    Published: 21-Nov-2017        Price: US 2000 Onwards        Pages: 104
    Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Axial Spondyloarthritis - Pipeline Review, H2 2017, provides an overview of the Axial Spondyloarthritis (Musculoskeletal Disorders) pipeline landscape.Axial spondylitis is a type of inflammatory arthritis involving the spine and/or sacroiliac joints. Axial spondylitis is strongly related to the presence of the HLA-B27 gene. A genetic test for HLA-B27 is available.Report HighlightsGlobal ......
  • Muscular Dystrophy - Pipeline Review, H2 2017
    Published: 21-Nov-2017        Price: US 2000 Onwards        Pages: 139
    Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Muscular Dystrophy - Pipeline Review, H2 2017, provides an overview of the Muscular Dystrophy (Musculoskeletal Disorders) pipeline landscape.Muscular dystrophy is a group of diseases in which muscle fibers are unusually susceptible to damage. These damaged muscles become progressively weaker. Symptoms usually appear before age 6 and may appear as early as infancy. They may include fatigue, learning difficultie......
  • Global Microbiome Therapeutics Market Professional Survey Report 2017
    Published: 15-Nov-2017        Price: US 3500 Onwards        Pages: 125
    This report studies Microbiome Therapeutics in Global market, especially in North America, China, Europe, Southeast Asia, Japan and India, with production, revenue, consumption, import and export in these regions, from 2012 to 2016, and forecast to 2022. This report focuses on top manufacturers in global market, with production, price, revenue and market share for each manufacturer, covering - C3 Jian - Enterome Bioscience - Immuron - MicroBiome Therap......
  • Aspergillosis - Pipeline Review, H2 2017
    Published: 14-Nov-2017        Price: US 2000 Onwards        Pages: 108
    Aspergillosis - Pipeline Review, H2 2017 Summary Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Aspergillosis - Pipeline Review, H2 2017, provides an overview of the Aspergillosis (Infectious Disease) pipeline landscape. Aspergillosis is an infection or allergic response due to the Aspergillus fungus. Symptoms include cough, fever, headaches, general ill feeling (malaise), weight loss and chest pain. The predisposing......
  • Cytomegalovirus (HHV-5) Infections - Pipeline Review, H2 2017
    Published: 14-Nov-2017        Price: US 2000 Onwards        Pages: 169
    Cytomegalovirus (HHV-5) Infections - Pipeline Review, H2 2017 Summary Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Cytomegalovirus (HHV-5) Infections - Pipeline Review, H2 2017, provides an overview of the Cytomegalovirus (HHV-5) Infections (Infectious Disease) pipeline landscape. Cytomegalovirus (CMV) is a contagious infection of the caused by the member of the herpes virus family. CMV is spread through saliva or ......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - sales@rnrmarketresearch.com / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs